BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 28397480)

  • 1. Genetic Polymorphism of MTHFR C677T Influences Susceptibility to HBV-Related Hepatocellular Carcinoma in a Chinese Population: a Case-Control Study.
    Qiao K; Zhang S; Trieu C; Dai Q; Huo Z; Du Y; Lu W; Hou W
    Clin Lab; 2017 Apr; 63(4):787-795. PubMed ID: 28397480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MTHFR C677T mutation is not a risk factor recognized for HBV-related HCC in a population with a high prevalence of this genetic marker.
    Jiao X; Luo Y; Yang B; Jing L; Li Y; Liu C; Jing X; Wang F; Wang Y; Du Z; Gao Y
    Infect Genet Evol; 2017 Apr; 49():66-72. PubMed ID: 28082187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LINE-1 Methylation in Chronic HBV Infected Patients: Association with HCC, Gender and MTHFR C677T Polymorphism.
    Qiao K; Zhang S; Huo Z; Hou W; Dai Q; Su R; Wang F
    Clin Lab; 2020 May; 66(5):. PubMed ID: 32390395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interrelationships among genetic C677T polymorphism of 5,10-methylenetetrahydrofolate reductase, biochemical folate status, and lymphocytic p53 oxidative damage in association with tumor malignancy and survivals of patients with hepatocellular carcinoma.
    Kuo CS; Huang CY; Kuo HT; Cheng CP; Chen CH; Lu CL; Yang FL; Syu Huang RF
    Mol Nutr Food Res; 2014 Feb; 58(2):329-42. PubMed ID: 23996892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of methylene-tetrahydrofolate reductase gene C677T and A1298C polymorphisms as a risk factor for hepatitis B virus infection.
    Karakus N; Yigit S; Kocak M; Bozkurt N; Duygu F
    Nucleosides Nucleotides Nucleic Acids; 2023; 42(9):683-695. PubMed ID: 36919686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylenetetrahydrofolate reductase C677T (Ala>Val, rs1801133 C>T) polymorphism decreases the susceptibility of hepatocellular carcinoma: a meta-analysis involving 12,628 subjects.
    Zhang S; Jiang J; Tang W; Liu L
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32010931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms and the risk of primary hepatocellular carcinoma (HCC) in a Chinese population.
    Mu LN; Cao W; Zhang ZF; Cai L; Jiang QW; You NC; Goldstein BY; Wei GR; Chen CW; Lu QY; Zhou XF; Ding BG; Chang J; Yu SZ
    Cancer Causes Control; 2007 Aug; 18(6):665-75. PubMed ID: 17503006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A study on the association of MTHFR C677T polymorphism with genetic susceptibility to hepatocellular carcinoma].
    Zhu ZZ; Cong WM; Liu SF; Xian ZH; Wu WQ
    Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):196-8. PubMed ID: 16556414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between
    Tan X; Chen H
    Front Endocrinol (Lausanne); 2023; 14():1273218. PubMed ID: 37964957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylenetetrahydrofolate reductase C677T mutation in patients with alopecia areata in Turkish population.
    Kalkan G; Yigit S; Karakuş N; Ateş O; Bozkurt N; Ozdemir A; Pancar GŞ
    Gene; 2013 Nov; 530(1):109-12. PubMed ID: 23954881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MTHFR C677T polymorphism and risk of HCC in patients with liver cirrhosis: role of male gender and alcohol consumption.
    Fabris C; Toniutto P; Falleti E; Fontanini E; Cussigh A; Bitetto D; Fornasiere E; Fumolo E; Avellini C; Minisini R; Pirisi M
    Alcohol Clin Exp Res; 2009 Jan; 33(1):102-7. PubMed ID: 18945219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant association between MTHFR C677T polymorphism and hepatocellular carcinoma risk: a meta-analysis.
    Sun H; Han B; Zhai H; Cheng X; Ma K
    Tumour Biol; 2014 Jan; 35(1):189-93. PubMed ID: 24132589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of MTHFR C677T and A1298C gene polymorphisms: association with the risk of hepatocellular carcinoma.
    Qi YH; Yao LP; Cui GB; Liang J; Shao QJ; Yan LF; Du P
    Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):172-80. PubMed ID: 24316043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) gene polymorphisms as risk factors for hepatocellular carcinoma in a Korean population.
    Kwak SY; Kim UK; Cho HJ; Lee HK; Kim HJ; Kim NK; Hwang SG
    Anticancer Res; 2008; 28(5A):2807-11. PubMed ID: 19035314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between MTHFR gene polymorphisms and the risk of autism spectrum disorders: a meta-analysis.
    Pu D; Shen Y; Wu J
    Autism Res; 2013 Oct; 6(5):384-92. PubMed ID: 23653228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene--nutrition interactions in coronary artery disease: correlation between the MTHFR C677T polymorphism and folate and homocysteine status in a Korean population.
    Huh HJ; Chi HS; Shim EH; Jang S; Park CJ
    Thromb Res; 2006; 117(5):501-6. PubMed ID: 15935452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between methylenetetrahydrofolate reductase polymorphisms and hepatocellular carcinoma risk in Chinese population.
    Qi X; Sun X; Xu J; Wang Z; Zhang J; Peng Z
    Tumour Biol; 2014 Mar; 35(3):1757-62. PubMed ID: 24385382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between MTHFR polymorphisms and cervical cancer risk: a system review and meta analysis.
    Yi K; Yang L; Lan Z; Xi M
    Arch Gynecol Obstet; 2016 Sep; 294(3):579-88. PubMed ID: 26879954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of MTHFR C677T polymorphism with severity and localization of chronic atrophic gastritis patients without Helicobacter pylori infection: a case control study.
    Kong S; Ye F; Dang Y; Hua Y; Zhang G
    BMC Cancer; 2020 Aug; 20(1):725. PubMed ID: 32758174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between MTHFR C677T Polymorphism and Risk of Prostate Cancer: Evidence from 22 Studies with 10,832 Cases and 11,993 Controls.
    Abedinzadeh M; Zare-Shehneh M; Neamatzadeh H; Abedinzadeh M; Karami H
    Asian Pac J Cancer Prev; 2015; 16(11):4525-30. PubMed ID: 26107198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.